3[3]Dietrich W, Mossinger H, Spannagl M, et al. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations [J]. J Thorac Cardiovasc Surg, 1993, 105(4): 712- 720.
4[4]Mojcik CF, Levy JH. Aprotinin and the systemic inflammatory response after cardiopulmonary bypass [J]. Ann Thorac Surg, 2001, 7(2): 745- 754.
5[5]Landis RC, Asimakopoulos G, Poullis M, et al. Effect of aprotinin (trasylol) on the inflammatory and thrombotic complications of conventional cardiopulmonary bypass surgery [J]. Heart Surg Forum, 2001, 4 (suppl) 1: s35- 39.
6[6]Asimakopoulos G, Lidington EA, Mason J, et al. Effect of aprotinin of endothelial cell activation [J]. J Thorac Cardiovasc Surg, 2001, 122(1): 123- 128.
7[7]Rahman A, Ustunda B, Burma O, et al. Does aprotinin reduce lung reperfusion damage after cardiopulmonary bypass[J]? Eur J Cardiothorac Surg, 2000, 18(5): 583- 588.
